GlassScriptPhysician profile
Jennifer Davis
NPI 1265949200
$1,911.84
in general payments reported to CMS, 2019-2025
27 companies · $412 in 2025
The $412 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $606 · 2022: $315 · 2023: $336 · 2024: $243 · 2025: $412.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $991.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $991.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $483.96 | 2021-2024 | Collagenase Santyl, Oasis, Versajet |
| Baxter Healthcare | $250.39 | 2022-2025 | Floseal, Recothrom, Tisseel |
| Boston Scientific Corporation | $157.89 | 2024-2025 | Intracept |
| Integra Lifesciences Corporation | $141.33 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $122.11 | 2023 | Andexxa |
| Amgen INC. | $119.50 | 2025 | Repatha |
| Kerecis Limited | $115.56 | 2021 | |
| Merck Sharp & Dohme LLC | $58.36 | 2022-2024 | Recarbrio, Zerbaxa, Dificid |
| Globus Medical, INC. | $57.34 | 2025 | Omnia, Senza |
| Forte Bio-Pharma LLC | $51.32 | 2022-2025 | Prolate, Nalocet, Tanlor |
| Convatec INC. | $42.23 | 2021-2023 | |
| Polynovo North America LLC | $32.15 | 2022 | |
| Ossur Americas, INC. | $31.50 | 2025 | |
| Stryker Corporation | $30.98 | 2022 | |
| Dexcom, INC. | $24.46 | 2024 | Dexcom G6 Transmitter |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $22.71 | 2024 | Ovitex 2s |
| Mallinckrodt Hospital Products INC. | $19.48 | 2022 | |
| Relievant Medsystems, INC. | $19.13 | 2022 | |
| Trevena, INC. | $18.95 | 2022 | |
| Redhill Biopharma INC. | $17.30 | 2021 | |
| Paratek Pharmaceuticals, INC. | $16.92 | 2021 | |
| Medline Industries LP | $16.92 | 2024 | Medline, Medline Industries, INC. |
| Mml US, INC. | $13.94 | 2023 | Reactiv8 |
| Myriad Genetic Laboratories, INC. | $13.89 | 2021 | |
| Avanos Medical | $13.86 | 2022 | |
| Coherus Oncology, INC. | $11.80 | 2022 | |
| Advanced Oxygen Therapy INC. | $7.86 | 2023 | Topical Oxygen Chamber For Extremities |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.